SLC22A2 Human (+)-artemisinin multiple interactions EXP 6480464 artemisinin inhibits the reaction [SLC22A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:27504015 SLC22A2 Human (+)-pilocarpine multiple interactions EXP 6480464 Pilocarpine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human (-)-noscapine multiple interactions EXP 6480464 Noscapine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human (-)-selegiline multiple interactions EXP 6480464 Selegiline inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human (E)-thiamethoxam decreases activity EXP 6480464 Thiamethoxam results in decreased activity of SLC22A2 protein CTD PMID:31364238 SLC22A2 Human (R)-carnitine decreases expression ISO Slc22a2 (Rattus norvegicus) 6480464 Carnitine results in decreased expression of SLC22A2 protein CTD PMID:25669660 SLC22A2 Human (S)-atropine multiple interactions EXP 6480464 Hyoscyamine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human (S)-fenfluramine multiple interactions EXP 6480464 Dexfenfluramine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human (S)-nicotine affects response to substance EXP 6480464 SLC22A2 gene SNP affects the susceptibility to Nicotine CTD PMID:25143296 SLC22A2 Human (S)-nicotine multiple interactions EXP 6480464 Nicotine inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:23770354 SLC22A2 Human 1,1'-diethyl-2,2'-cyanine multiple interactions EXP 6480464 pseudoisocyanine inhibits the reaction [SLC22A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:12110607 SLC22A2 Human 1,1-dichloroethene decreases expression ISO Slc22a2 (Mus musculus) 6480464 vinylidene chloride results in decreased expression of SLC22A2 mRNA CTD PMID:26682919 SLC22A2 Human 1,3-diphenylguanidine multiple interactions EXP 6480464 diphenylguanidine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human 1-[(4-chlorophenyl)-phenylmethyl]-4-methyl-1,4-diazepane multiple interactions EXP 6480464 homochlorocyclizine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human 1-\{2-[(4-chlorobenzyl)sulfanyl]-2-(2,4-dichlorophenyl)ethyl\}-1H-imidazole multiple interactions EXP 6480464 sulconazole inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases response to substance ISO Slc22a2 (Mus musculus) 6480464 SLC22A2 protein results in increased susceptibility to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine CTD PMID:25248837 SLC22A2 Human 1-methylnicotinamide increases import EXP 6480464 SLC22A2 results in increased import of N(1)-methylnicotinamide CTD PMID:9260930 SLC22A2 Human 1-naphthyl isothiocyanate increases expression ISO Slc22a2 (Mus musculus) 6480464 1-Naphthylisothiocyanate results in increased expression of SLC22A2 mRNA CTD PMID:15913567 SLC22A2 Human 1-naphthyl isothiocyanate multiple interactions ISO Slc22a2 (Mus musculus) 6480464 O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLC22A2 mRNA] CTD PMID:15913567 SLC22A2 Human 11-deoxycorticosterone multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 Desoxycorticosterone inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:9830022 SLC22A2 Human 17alpha-ethynylestradiol decreases expression ISO Slc22a2 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in decreased expression of SLC22A2 mRNA; Ethinyl Estradiol results in decreased expression more ... CTD PMID:19002567 SLC22A2 Human 17alpha-hydroxyprogesterone multiple interactions EXP 6480464 17-alpha-Hydroxyprogesterone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human 17beta-estradiol multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 Estradiol affects the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:9830022 SLC22A2 Human 2-(1-naphthalenylmethyl)-4,5-dihydro-1H-imidazole multiple interactions EXP 6480464 Naphazoline inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile multiple interactions EXP 6480464 Verapamil inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 Verapamil inhibits the reaction [SLC22A2 protein results in increased uptake of mepiquat] CTD PMID:33639197 SLC22A2 Human 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one multiple interactions EXP 6480464 Praziquantel inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human 2-Amino-3-methyl-9H-pyrido[2,3-b]indole decreases activity EXP 6480464 2-amino-3-methyl-9H-pyrido(2,3-b)indole results in decreased activity of SLC22A2 protein CTD PMID:30189235 SLC22A2 Human 2-Amino-3-methyl-9H-pyrido[2,3-b]indole multiple interactions EXP 6480464 2-amino-3-methyl-9H-pyrido(2,3-b)indole inhibits the reaction [SLC22A2 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide] CTD PMID:30189235 SLC22A2 Human 2-Amino-9H-pyrido[2,3-b]indole multiple interactions EXP 6480464 2-amino-9H-pyrido(2,3-b)indole inhibits the reaction [SLC22A2 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide] CTD PMID:30189235 SLC22A2 Human 2-Amino-9H-pyrido[2,3-b]indole decreases activity EXP 6480464 2-amino-9H-pyrido(2,3-b)indole results in decreased activity of SLC22A2 protein CTD PMID:30189235 SLC22A2 Human 2-hydroxy-2,2-diphenylacetic acid (1,1-dimethyl-3-piperidin-1-iumyl) ester multiple interactions EXP 6480464 mepenzolic acid inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human 2-hydroxy-2,2-diphenylacetic acid (1-methyl-1-azoniabicyclo[2.2.2]octan-3-yl) ester multiple interactions EXP 6480464 clidinium inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human 2-methyl-1-(4-methylphenyl)-3-(1-piperidinyl)-1-propanone multiple interactions EXP 6480464 Tolperisone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine affects expression ISO Slc22a2 (Rattus norvegicus) 6480464 Puromycin Aminonucleoside affects the expression of SLC22A2 mRNA CTD PMID:22005293 SLC22A2 Human 3,3',4',5-tetrachlorosalicylanilide multiple interactions EXP 6480464 3,3',4',5-tetrachlorosalicylanilide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP 6480464 tetrabromobisphenol A inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:27989701 SLC22A2 Human 3,4,8-Trimethyl-1H,2H,3H-imidazo[4,5-F]quinoxalin-2-imine decreases activity EXP 6480464 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in decreased activity of SLC22A2 protein CTD PMID:30189235 SLC22A2 Human 3,4,8-Trimethyl-1H,2H,3H-imidazo[4,5-F]quinoxalin-2-imine multiple interactions EXP 6480464 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine inhibits the reaction [SLC22A2 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide] CTD PMID:30189235 SLC22A2 Human 3,4-dimethoxybenzoic acid 4-[ethyl-[1-(4-methoxyphenyl)propan-2-yl]amino]butyl ester multiple interactions EXP 6480464 mebeverine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human 3-[2-(ethylamino)-1-hydroxyethyl]phenol multiple interactions EXP 6480464 Etilefrine inhibits the reaction [SLC22A2 protein results in increased transport of 1-Methyl-4-phenylpyridinium] CTD PMID:16263091 SLC22A2 Human 3-Amino-1-methyl-5H-pyrido[4,3-b]indole decreases activity EXP 6480464 3-amino-1-methyl-5H-pyrido(4,3-b)indole results in decreased activity of SLC22A2 protein CTD PMID:30189235 SLC22A2 Human 3-Amino-1-methyl-5H-pyrido[4,3-b]indole multiple interactions EXP 6480464 3-amino-1-methyl-5H-pyrido(4,3-b)indole inhibits the reaction [SLC22A2 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide]; 3-amino-1-methyl-5H-pyrido(4,3-b)indole inhibits more ... CTD PMID:30189235 SLC22A2 Human 3-chloropropane-1,2-diol decreases expression ISO Slc22a2 (Rattus norvegicus) 6480464 alpha-Chlorohydrin results in decreased expression of SLC22A2 protein CTD PMID:34915118 SLC22A2 Human 4,4'-diaminodiphenylmethane increases expression ISO Slc22a2 (Mus musculus) 6480464 4,4'-diaminodiphenylmethane results in increased expression of SLC22A2 mRNA CTD PMID:18648102 SLC22A2 Human 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 bisphenol S promotes the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:27989701 SLC22A2 Human 4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxyphenyl)-1-butanone multiple interactions EXP 6480464 buflomedil inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human 4-[1-hydroxy-2-(4-phenylbutan-2-ylamino)propyl]phenol multiple interactions EXP 6480464 Nylidrin inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human 4-[6-(diaminomethylideneamino)-1-oxohexoxy]benzoic acid ethyl ester multiple interactions EXP 6480464 Gabexate inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human 4-amino-5-chloro-2-methoxy-N-[1-(phenylmethyl)-4-piperidinyl]benzamide multiple interactions EXP 6480464 clebopride inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human 4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide multiple interactions EXP 6480464 Cisapride inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human 5-azaorotic acid decreases expression ISO Slc22a2 (Rattus norvegicus) 6480464 Oxonic Acid results in decreased expression of SLC22A2 protein CTD PMID:19605544 SLC22A2 Human 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole multiple interactions EXP 6480464 Omeprazole inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human 6-propyl-2-thiouracil decreases expression ISO Slc22a2 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of SLC22A2 mRNA CTD PMID:24780913 SLC22A2 Human 9-aminoacridine multiple interactions EXP 6480464 Aminacrine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human [2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol multiple interactions EXP 6480464 Mefloquine inhibits the reaction [SLC22A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:27504015 SLC22A2 Human AB-Fubinaca decreases activity EXP 6480464 AB-FUBINACA results in decreased activity of SLC22A2 protein CTD PMID:33050066 SLC22A2 Human acetamiprid decreases activity EXP 6480464 acetamiprid results in decreased activity of SLC22A2 protein CTD PMID:31364238 SLC22A2 Human acetylsalicylic acid affects response to substance EXP 6480464 SLC22A2 polymorphism affects the susceptibility to Aspirin CTD PMID:21346370 SLC22A2 Human aclacinomycin A multiple interactions EXP 6480464 Aclarubicin inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human aconitine multiple interactions EXP 6480464 Aconitine inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:23770354 SLC22A2 Human adapalene multiple interactions EXP 6480464 Adapalene inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human adrenosterone multiple interactions EXP 6480464 adrenosterone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human aflatoxin B1 increases methylation EXP 6480464 Aflatoxin B1 results in increased methylation of SLC22A2 gene CTD PMID:27153756 SLC22A2 Human all-trans-retinoic acid multiple interactions EXP 6480464 Tretinoin inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human allopurinol multiple interactions ISO Slc22a2 (Mus musculus) 6480464 Allopurinol inhibits the reaction [potassium oxonate results in decreased expression of SLC22A2 mRNA]; Allopurinol inhibits more ... CTD PMID:21909718|PMID:22865646 SLC22A2 Human allopurinol multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 Allopurinol inhibits the reaction [Fructose results in decreased expression of SLC22A2 mRNA]; Allopurinol inhibits the more ... CTD PMID:19605544 SLC22A2 Human alprazolam multiple interactions EXP 6480464 Alprazolam inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human alprenolol multiple interactions EXP 6480464 Alprenolol inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human amiloride multiple interactions EXP 6480464 Amiloride inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human amitraz multiple interactions EXP 6480464 amitraz inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human amitriptyline multiple interactions EXP 6480464 Amitriptyline inhibits the reaction [SLC22A2 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide]; Amitriptyline inhibits more ... CTD PMID:21599003|PMID:23770354|PMID:28629854|PMID:30189235 SLC22A2 Human amitriptyline decreases activity EXP 6480464 Amitriptyline results in decreased activity of SLC22A2 protein CTD PMID:28629854|PMID:31364238 SLC22A2 Human ammonium chloride affects expression ISO Slc22a2 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of SLC22A2 mRNA CTD PMID:16483693 SLC22A2 Human anastrozole multiple interactions EXP 6480464 anastrozole inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human androsterone multiple interactions EXP 6480464 Androsterone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human angelicin increases expression ISO Slc22a2 (Mus musculus) 6480464 angelicin results in increased expression of SLC22A2 mRNA; angelicin results in increased expression of SLC22A2 more ... CTD PMID:22173200 SLC22A2 Human antazoline multiple interactions EXP 6480464 Antazoline inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human apomorphine multiple interactions EXP 6480464 Apomorphine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human aristolochic acids decreases expression ISO Slc22a2 (Rattus norvegicus) 6480464 Aristolochic Acids results in decreased expression of SLC22A2 mRNA; Aristolochic Acids results in decreased expression more ... CTD PMID:21167265 SLC22A2 Human atrazine affects methylation ISO Slc22a2 (Rattus norvegicus) 6480464 Atrazine affects the methylation of SLC22A2 gene CTD PMID:28931070 SLC22A2 Human atropine multiple interactions EXP 6480464 Atropine inhibits the reaction [SLC22A2 protein results in increased transport of 1-Methyl-4-phenylpyridinium]; Atropine inhibits the more ... CTD PMID:16263091|PMID:21599003|PMID:23770354 SLC22A2 Human auranofin multiple interactions EXP 6480464 Auranofin inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human azelastine multiple interactions EXP 6480464 azelastine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human azithromycin multiple interactions EXP 6480464 Azithromycin inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human bazedoxifene multiple interactions EXP 6480464 bazedoxifene inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human beclomethasone multiple interactions EXP 6480464 Beclomethasone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human benzatropine multiple interactions EXP 6480464 Benztropine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human benzethonium chloride multiple interactions EXP 6480464 Benzethonium inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human benzo[a]pyrene increases mutagenesis EXP 6480464 Benzo(a)pyrene results in increased mutagenesis of SLC22A2 gene CTD PMID:25435355 SLC22A2 Human benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of SLC22A2 mRNA CTD PMID:32234424 SLC22A2 Human benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of SLC22A2 exon CTD PMID:27901495 SLC22A2 Human benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of SLC22A2 promoter CTD PMID:27901495 SLC22A2 Human benzo[a]pyrene increases expression ISO Slc22a2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of SLC22A2 mRNA CTD PMID:22228805 SLC22A2 Human beta-carboline multiple interactions EXP 6480464 norharman inhibits the reaction [SLC22A2 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide] CTD PMID:30189235 SLC22A2 Human beta-carboline decreases activity EXP 6480464 norharman results in decreased activity of SLC22A2 protein CTD PMID:30189235 SLC22A2 Human bisoprolol multiple interactions EXP 6480464 Bisoprolol inhibits the reaction [SLC22A2 protein results in increased uptake of Metformin] CTD PMID:19740083 SLC22A2 Human bisphenol A decreases expression ISO Slc22a2 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of SLC22A2 mRNA CTD PMID:25181051|PMID:30816183|PMID:32528016 SLC22A2 Human bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of SLC22A2 gene CTD PMID:31601247 SLC22A2 Human bisphenol F multiple interactions EXP 6480464 bisphenol F promotes the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:27989701 SLC22A2 Human bithionol multiple interactions EXP 6480464 Bithionol inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human bopindolol multiple interactions EXP 6480464 bopindolol inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human bretylium tosylate multiple interactions EXP 6480464 Bretylium Tosylate inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human brilliant green multiple interactions EXP 6480464 brilliant green inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human brimonidine tartrate multiple interactions EXP 6480464 Brimonidine Tartrate inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human bromhexine multiple interactions EXP 6480464 Bromhexine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human brompheniramine multiple interactions EXP 6480464 Brompheniramine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human budesonide multiple interactions EXP 6480464 Budesonide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human bupropion multiple interactions EXP 6480464 Bupropion inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human buspirone multiple interactions EXP 6480464 Buspirone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human butenafine multiple interactions EXP 6480464 butenafine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human Butylparaben multiple interactions EXP 6480464 butylparaben inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human butylscopolamine bromide multiple interactions EXP 6480464 Butylscopolammonium Bromide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human cadmium dichloride decreases expression ISO Slc22a2 (Rattus norvegicus) 6480464 Cadmium Chloride results in decreased expression of SLC22A2 mRNA; Cadmium Chloride results in decreased expression more ... CTD PMID:25588984 SLC22A2 Human capsaicin multiple interactions EXP 6480464 Capsaicin inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human carbinoxamine multiple interactions EXP 6480464 carbinoxamine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human carvedilol multiple interactions EXP 6480464 Carvedilol inhibits the reaction [SLC22A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Carvedilol inhibits the more ... CTD PMID:19740083|PMID:21599003 SLC22A2 Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC22A2 gene] CTD PMID:28238834 SLC22A2 Human chlorhexidine multiple interactions EXP 6480464 Chlorhexidine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human Chlormadinone acetate multiple interactions EXP 6480464 Chlormadinone Acetate inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human chlorogenic acid multiple interactions ISO Slc22a2 (Mus musculus) 6480464 Chlorogenic Acid inhibits the reaction [Cisplatin results in decreased expression of SLC22A2 protein] CTD PMID:25043994 SLC22A2 Human chloroquine multiple interactions EXP 6480464 Chloroquine inhibits the reaction [SLC22A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:27504015 SLC22A2 Human chlorphenamine multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 Chlorpheniramine affects the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:12440152 SLC22A2 Human chlorphenamine multiple interactions EXP 6480464 Chlorpheniramine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human chlorphenesin carbamate multiple interactions EXP 6480464 chlorphenesin carbamate inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human chlorpromazine multiple interactions EXP 6480464 Chlorpromazine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human chlorpyrifos multiple interactions EXP 6480464 Chlorpyrifos inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:23770354 SLC22A2 Human ciguatoxin CTX1B affects expression ISO Slc22a2 (Mus musculus) 6480464 Ciguatoxins affects the expression of SLC22A2 mRNA CTD PMID:18353800 SLC22A2 Human cilostazol multiple interactions EXP 6480464 cilostazol inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human cimetidine multiple interactions EXP 6480464 1-Methyl-4-phenylpyridinium inhibits the reaction [SLC22A2 protein results in increased uptake of Cimetidine]; Cimetidine inhibits the more ... CTD PMID:15496291|PMID:19357179|PMID:21599003 SLC22A2 Human cimetidine increases transport ISO Slc22a2 (Rattus norvegicus) 6480464 SLC22A2 protein results in increased transport of Cimetidine CTD PMID:18230276 SLC22A2 Human cimetidine decreases response to substance EXP 6480464 SLC22A2 gene polymorphism results in decreased susceptibility to Cimetidine CTD PMID:22525860 SLC22A2 Human cimetidine increases uptake EXP 6480464 SLC22A2 protein results in increased uptake of Cimetidine CTD PMID:15496291|PMID:16006492 SLC22A2 Human cimetidine increases uptake ISO Slc22a2 (Rattus norvegicus) 6480464 SLC22A2 protein results in increased uptake of Cimetidine CTD PMID:16006492 SLC22A2 Human cisapride multiple interactions EXP 6480464 Cisapride inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human cisplatin multiple interactions ISO Slc22a2 (Mus musculus) 6480464 [SLC22A2 protein affects the susceptibility to Cisplatin] which affects the expression of SPRR1A protein; Chlorogenic more ... CTD PMID:25043994|PMID:31493026 SLC22A2 Human cisplatin affects response to substance ISO Slc22a2 (Mus musculus) 6480464 SLC22A2 protein affects the susceptibility to Cisplatin CTD PMID:31493026 SLC22A2 Human cisplatin increases response to substance ISO Slc22a2 (Mus musculus) 6480464 SLC22A2 protein results in increased susceptibility to Cisplatin CTD PMID:21599003 SLC22A2 Human cisplatin multiple interactions EXP 6480464 SLC22A2 gene polymorphism inhibits the reaction [Cisplatin results in increased expression of CST3] CTD PMID:22525860 SLC22A2 Human cisplatin decreases response to substance EXP 6480464 SLC22A2 gene polymorphism results in decreased susceptibility to Cisplatin CTD PMID:22525860 SLC22A2 Human cisplatin affects expression ISO Slc22a2 (Rattus norvegicus) 6480464 Cisplatin affects the expression of SLC22A2 mRNA CTD PMID:22005293 SLC22A2 Human cisplatin decreases expression ISO Slc22a2 (Mus musculus) 6480464 Cisplatin results in decreased expression of SLC22A2 mRNA; Cisplatin results in decreased expression of SLC22A2 more ... CTD PMID:25043994|PMID:31493026 SLC22A2 Human clidinium multiple interactions EXP 6480464 clidinium inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human clomacran multiple interactions EXP 6480464 clomacran inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human clomipramine multiple interactions EXP 6480464 Clomipramine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human clonidine multiple interactions EXP 6480464 Clonidine inhibits the reaction [SLC22A2 protein results in increased transport of 1-Methyl-4-phenylpyridinium]; Clonidine inhibits the more ... CTD PMID:16263091|PMID:21599003 SLC22A2 Human clonidine (amino form) multiple interactions EXP 6480464 Clonidine inhibits the reaction [SLC22A2 protein results in increased transport of 1-Methyl-4-phenylpyridinium]; Clonidine inhibits the more ... CTD PMID:16263091|PMID:21599003 SLC22A2 Human clonidine (imino form) multiple interactions EXP 6480464 Clonidine inhibits the reaction [SLC22A2 protein results in increased transport of 1-Methyl-4-phenylpyridinium]; Clonidine inhibits the more ... CTD PMID:16263091|PMID:21599003 SLC22A2 Human clorprenaline multiple interactions EXP 6480464 clorprenaline inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human clothianidin decreases activity EXP 6480464 clothianidin results in decreased activity of SLC22A2 protein CTD PMID:31364238 SLC22A2 Human clozapine multiple interactions EXP 6480464 Clozapine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human corticosterone multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 Corticosterone inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:9830022 SLC22A2 Human cortisol multiple interactions EXP 6480464 Hydrocortisone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human cortisone multiple interactions EXP 6480464 Cortisone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human crystal violet multiple interactions EXP 6480464 Gentian Violet inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human cyclobenzaprine multiple interactions EXP 6480464 cyclobenzaprine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human cyclosporin A decreases expression ISO Slc22a2 (Rattus norvegicus) 6480464 Cyclosporine results in decreased expression of SLC22A2 mRNA CTD PMID:21865292 SLC22A2 Human cyclosporin A affects expression ISO Slc22a2 (Rattus norvegicus) 6480464 Cyclosporine affects the expression of SLC22A2 mRNA CTD PMID:22005293 SLC22A2 Human cyproheptadine multiple interactions EXP 6480464 Cyproheptadine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human cyromazine multiple interactions EXP 6480464 cyromazine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human decabromodiphenyl ether increases expression ISO Slc22a2 (Rattus norvegicus) 6480464 decabromobiphenyl ether results in increased expression of SLC22A2 mRNA CTD PMID:23914054 SLC22A2 Human dequalinium multiple interactions EXP 6480464 Dequalinium inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human desipramine multiple interactions EXP 6480464 Desipramine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human desloratadine multiple interactions EXP 6480464 desloratadine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human desoximetasone multiple interactions EXP 6480464 Desoximetasone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human dexbrompheniramine multiple interactions EXP 6480464 dexbrompheniramine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human dexchlorpheniramine multiple interactions EXP 6480464 dexchlorpheniramine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human dextromethorphan multiple interactions EXP 6480464 Dextromethorphan inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human dextropropoxyphene multiple interactions EXP 6480464 Dextropropoxyphene inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human diazepam multiple interactions EXP 6480464 Diazepam inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human dibenzofurans increases expression ISO Slc22a2 (Mus musculus) 6480464 Dibenzofurans results in increased expression of SLC22A2 mRNA CTD PMID:34254344 SLC22A2 Human dichlorine multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 [Ozone co-treated with Chlorine] results in increased expression of SLC22A2 mRNA CTD PMID:18636392 SLC22A2 Human dicyclomine multiple interactions EXP 6480464 Dicyclomine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human digitonin multiple interactions EXP 6480464 Digitonin inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human dimenhydrinate multiple interactions EXP 6480464 Dimenhydrinate inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human dimethyl-(phenylmethyl)-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]ammonium multiple interactions EXP 6480464 Benzethonium inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human dioxygen decreases expression ISO Slc22a2 (Mus musculus) 6480464 Oxygen deficiency results in decreased expression of SLC22A2 mRNA CTD PMID:24205000 SLC22A2 Human diphenhydramine multiple interactions EXP 6480464 Diphenhydramine inhibits the reaction [SLC22A2 protein results in increased transport of 1-Methyl-4-phenylpyridinium]; Diphenhydramine inhibits the more ... CTD PMID:16263091|PMID:21599003 SLC22A2 Human diphenidol multiple interactions EXP 6480464 diphenidol inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human dipyridamole multiple interactions EXP 6480464 Dipyridamole inhibits the reaction [SLC22A2 protein polymorphism results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]; Dipyridamole inhibits more ... CTD PMID:21599003 SLC22A2 Human disodium selenite decreases expression EXP 6480464 Sodium Selenite results in decreased expression of SLC22A2 mRNA CTD PMID:18175754 SLC22A2 Human disopyramide multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 Disopyramide affects the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:12440152 SLC22A2 Human disopyramide multiple interactions EXP 6480464 Disopyramide inhibits the reaction [SLC22A2 protein polymorphism results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]; Disopyramide inhibits more ... CTD PMID:21599003 SLC22A2 Human domperidone multiple interactions EXP 6480464 Domperidone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human donepezil hydrochloride multiple interactions EXP 6480464 Donepezil inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human dopamine multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 Dopamine affects the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:12440152 SLC22A2 Human doxazosin multiple interactions EXP 6480464 Doxazosin inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human doxepin multiple interactions EXP 6480464 Doxepin inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human doxepin multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 Doxepin inhibits the reaction [SLC22A2 protein results in increased uptake of mepiquat] CTD PMID:33639197 SLC22A2 Human droperidol multiple interactions EXP 6480464 Droperidol inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human dyclonine multiple interactions EXP 6480464 dyclonine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human econazole multiple interactions EXP 6480464 Econazole inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human epalrestat multiple interactions EXP 6480464 epalrestat inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human Eperisone hydrochloride multiple interactions EXP 6480464 eperisone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human epinastine multiple interactions EXP 6480464 epinastine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human estrone multiple interactions EXP 6480464 Estrone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human ethidium increases uptake EXP 6480464 SLC22A2 protein results in increased uptake of Ethidium CTD PMID:19357179 SLC22A2 Human ethidium multiple interactions EXP 6480464 1-Methyl-4-phenylpyridinium inhibits the reaction [SLC22A2 protein results in increased uptake of Ethidium]; Cimetidine inhibits the more ... CTD PMID:19357179 SLC22A2 Human ethidium affects uptake ISO Slc22a2 (Mus musculus) 6480464 SLC22A2 protein affects the uptake of Ethidium CTD PMID:19357179 SLC22A2 Human exemestane multiple interactions EXP 6480464 exemestane inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human famotidine increases uptake EXP 6480464 SLC22A2 protein results in increased uptake of Famotidine CTD PMID:16006492 SLC22A2 Human famotidine increases uptake ISO Slc22a2 (Rattus norvegicus) 6480464 SLC22A2 protein results in increased uptake of Famotidine CTD PMID:16006492 SLC22A2 Human famotidine multiple interactions EXP 6480464 Famotidine inhibits the reaction [SLC22A2 protein affects the transport of Tetraethylammonium]; Famotidine inhibits the reaction more ... CTD PMID:15496291|PMID:16141367|PMID:21599003 SLC22A2 Human fenitrothion multiple interactions EXP 6480464 Fenitrothion inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:23770354 SLC22A2 Human finasteride multiple interactions EXP 6480464 Finasteride inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human flumazenil multiple interactions EXP 6480464 Flumazenil inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human fluorometholone multiple interactions EXP 6480464 Fluorometholone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human fluoxetine multiple interactions EXP 6480464 Fluoxetine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human fluphenazine multiple interactions EXP 6480464 Fluphenazine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human Flurandrenolide multiple interactions EXP 6480464 Flurandrenolone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human formononetin decreases expression ISO Slc22a2 (Rattus norvegicus) 6480464 formononetin results in decreased expression of SLC22A2 mRNA CTD PMID:28414026 SLC22A2 Human fructose decreases expression ISO Slc22a2 (Rattus norvegicus) 6480464 Fructose results in decreased expression of SLC22A2 mRNA; Fructose results in decreased expression of SLC22A2 more ... CTD PMID:19605544 SLC22A2 Human fructose multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 Allopurinol inhibits the reaction [Fructose results in decreased expression of SLC22A2 mRNA]; Allopurinol inhibits the more ... CTD PMID:19605544 SLC22A2 Human fulvestrant multiple interactions EXP 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of SLC22A2 gene CTD PMID:31601247 SLC22A2 Human genistein increases expression ISO Slc22a2 (Mus musculus) 6480464 Genistein results in increased expression of SLC22A2 mRNA CTD PMID:32186404 SLC22A2 Human gentamycin increases transport EXP 6480464 SLC22A2 protein results in increased transport of Gentamicins CTD PMID:27401566 SLC22A2 Human gentamycin affects expression ISO Slc22a2 (Rattus norvegicus) 6480464 Gentamicins affects the expression of SLC22A2 mRNA CTD PMID:22005293 SLC22A2 Human gentamycin decreases expression ISO Slc22a2 (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of SLC22A2 mRNA; Gentamicins results in decreased expression of SLC22A2 more ... CTD PMID:22061828|PMID:29460972 SLC22A2 Human Glu-P-1 multiple interactions EXP 6480464 2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole inhibits the reaction [SLC22A2 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide] CTD PMID:30189235 SLC22A2 Human Glu-P-1 decreases activity EXP 6480464 2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole results in decreased activity of SLC22A2 protein CTD PMID:30189235 SLC22A2 Human Glu-P-2 decreases activity EXP 6480464 Glu-P-2 results in decreased activity of SLC22A2 protein CTD PMID:30189235 SLC22A2 Human Glu-P-2 multiple interactions EXP 6480464 Glu-P-2 inhibits the reaction [SLC22A2 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide] CTD PMID:30189235 SLC22A2 Human glycyrrhizinic acid multiple interactions EXP 6480464 Glycyrrhizic Acid inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human glyphosate increases expression ISO Slc22a2 (Mus musculus) 6480464 Glyphosate results in increased expression of SLC22A2 mRNA CTD PMID:33713393 SLC22A2 Human granisetron multiple interactions EXP 6480464 Granisetron inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human GSK-J4 increases expression EXP 6480464 GSK-J4 results in increased expression of SLC22A2 mRNA CTD PMID:29301935 SLC22A2 Human Guanabenz multiple interactions EXP 6480464 Guanabenz inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human Guanfacine multiple interactions EXP 6480464 Guanfacine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human Halcinonide multiple interactions EXP 6480464 Halcinonide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human haloperidol multiple interactions EXP 6480464 Haloperidol inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:23770354 SLC22A2 Human harman multiple interactions EXP 6480464 harman inhibits the reaction [SLC22A2 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide] CTD PMID:30189235 SLC22A2 Human harman decreases activity EXP 6480464 harman results in decreased activity of SLC22A2 protein CTD PMID:30189235 SLC22A2 Human Homatropine multiple interactions EXP 6480464 homatropine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human hydralazine multiple interactions EXP 6480464 Hydralazine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human hydroxyzine multiple interactions EXP 6480464 Hydroxyzine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human idebenone multiple interactions EXP 6480464 idebenone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human imidacloprid decreases activity EXP 6480464 imidacloprid results in decreased activity of SLC22A2 protein CTD PMID:31364238 SLC22A2 Human imipramine multiple interactions EXP 6480464 Imipramine inhibits the reaction [SLC22A2 protein polymorphism results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]; Imipramine inhibits more ... CTD PMID:21599003 SLC22A2 Human imperatorin increases expression ISO Slc22a2 (Mus musculus) 6480464 imperatorin results in increased expression of SLC22A2 protein CTD PMID:22173200 SLC22A2 Human imperatorin decreases expression ISO Slc22a2 (Mus musculus) 6480464 imperatorin results in decreased expression of SLC22A2 mRNA CTD PMID:22173200 SLC22A2 Human indapamide multiple interactions EXP 6480464 Indapamide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human indometacin decreases activity EXP 6480464 Indomethacin results in decreased activity of SLC22A2 protein CTD PMID:12388633 SLC22A2 Human ipratropium multiple interactions EXP 6480464 Ipratropium inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human isoimperatorin increases expression ISO Slc22a2 (Mus musculus) 6480464 isoimperatorin results in increased expression of SLC22A2 protein CTD PMID:22173200 SLC22A2 Human isoimperatorin decreases expression ISO Slc22a2 (Mus musculus) 6480464 isoimperatorin results in decreased expression of SLC22A2 mRNA CTD PMID:22173200 SLC22A2 Human Isopropamide iodide multiple interactions EXP 6480464 isopropamide iodide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human kainic acid multiple interactions EXP 6480464 Kainic Acid inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human ketotifen multiple interactions EXP 6480464 Ketotifen inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human L-744832 multiple interactions EXP 6480464 L 744832 inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human Lafutidine multiple interactions EXP 6480464 lafutidine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human lamivudine increases uptake EXP 6480464 SLC22A2 protein results in increased uptake of Lamivudine CTD PMID:19141712 SLC22A2 Human lansoprazole multiple interactions EXP 6480464 Lansoprazole inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human letrozole multiple interactions EXP 6480464 letrozole inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human leuprolide multiple interactions EXP 6480464 Leuprolide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human Licochalcone B decreases expression EXP 6480464 licochalcone B results in decreased expression of SLC22A2 mRNA CTD PMID:33647349 SLC22A2 Human lidocaine multiple interactions EXP 6480464 Lidocaine inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:23770354 SLC22A2 Human lisuride multiple interactions EXP 6480464 Lisuride inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human loperamide multiple interactions EXP 6480464 Loperamide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human lysergol multiple interactions EXP 6480464 lysergol inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human malathion multiple interactions EXP 6480464 Malathion inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:23770354 SLC22A2 Human maneb multiple interactions ISO Slc22a2 (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in decreased expression of SLC22A2 mRNA; Melatonin inhibits the reaction more ... CTD PMID:23963992 SLC22A2 Human mangiferin increases expression ISO Slc22a2 (Mus musculus) 6480464 mangiferin results in increased expression of SLC22A2 mRNA CTD PMID:21348301 SLC22A2 Human Maprotiline multiple interactions EXP 6480464 Maprotiline inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human mechlorethamine multiple interactions EXP 6480464 Mechlorethamine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human medroxyprogesterone multiple interactions EXP 6480464 Medroxyprogesterone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human mefloquine multiple interactions EXP 6480464 Mefloquine inhibits the reaction [SLC22A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:27504015 SLC22A2 Human megestrol acetate multiple interactions EXP 6480464 Megestrol Acetate inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human MeIQ decreases activity EXP 6480464 2-amino-3,4-dimethylimidazo(4,5-f)quinoline results in decreased activity of SLC22A2 protein CTD PMID:30189235 SLC22A2 Human MeIQ multiple interactions EXP 6480464 2-amino-3,4-dimethylimidazo(4,5-f)quinoline inhibits the reaction [SLC22A2 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide] CTD PMID:30189235 SLC22A2 Human MeIQx multiple interactions EXP 6480464 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline inhibits the reaction [SLC22A2 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide] CTD PMID:30189235 SLC22A2 Human MeIQx decreases activity EXP 6480464 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in decreased activity of SLC22A2 protein CTD PMID:30189235 SLC22A2 Human melatonin multiple interactions ISO Slc22a2 (Mus musculus) 6480464 Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of SLC22A2 mRNA] CTD PMID:23963992 SLC22A2 Human melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human Mepenzolate multiple interactions EXP 6480464 mepenzolic acid inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human mepiquat increases uptake ISO Slc22a2 (Rattus norvegicus) 6480464 SLC22A2 protein results in increased uptake of mepiquat CTD PMID:33639197 SLC22A2 Human mepiquat multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 Doxepin inhibits the reaction [SLC22A2 protein results in increased uptake of mepiquat]; Verapamil inhibits the more ... CTD PMID:33639197 SLC22A2 Human mepyramine multiple interactions EXP 6480464 Pyrilamine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human mercury dichloride multiple interactions EXP 6480464 [Mercuric Chloride results in decreased activity of SLC22A2 protein] which results in decreased uptake of more ... CTD PMID:17287197 SLC22A2 Human mercury dichloride decreases expression ISO Slc22a2 (Rattus norvegicus) 6480464 Mercuric Chloride results in decreased expression of SLC22A2 mRNA CTD PMID:28536007 SLC22A2 Human mercury dichloride decreases activity EXP 6480464 Mercuric Chloride results in decreased activity of SLC22A2 protein CTD PMID:17287197 SLC22A2 Human Mestanolone multiple interactions EXP 6480464 mestanolone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human metformin multiple interactions EXP 6480464 Bisoprolol inhibits the reaction [SLC22A2 protein results in increased uptake of Metformin]; carvedilol inhibits the more ... CTD PMID:16141367|PMID:18728938|PMID:19740083|PMID:24001450 SLC22A2 Human metformin increases transport ISO Slc22a2 (Rattus norvegicus) 6480464 SLC22A2 protein results in increased transport of Metformin CTD PMID:18230276 SLC22A2 Human metformin increases uptake ISO Slc22a2 (Mus musculus) 6480464 SLC22A2 protein results in increased uptake of Metformin CTD PMID:24001450 SLC22A2 Human metformin increases uptake EXP 6480464 SLC22A2 protein results in increased uptake of Metformin CTD PMID:19740083|PMID:24001450|PMID:32305507 SLC22A2 Human metformin multiple interactions ISO Slc22a2 (Mus musculus) 6480464 Ondansetron inhibits the reaction [SLC22A2 protein results in increased uptake of Metformin] CTD PMID:24001450 SLC22A2 Human metformin decreases transport EXP 6480464 SLC22A2 protein mutant form results in decreased transport of Metformin CTD PMID:18728938 SLC22A2 Human metformin affects transport EXP 6480464 SLC22A2 protein affects the transport of Metformin CTD PMID:18728938 SLC22A2 Human methoxsalen decreases expression ISO Slc22a2 (Mus musculus) 6480464 Methoxsalen results in decreased expression of SLC22A2 mRNA CTD PMID:22173200 SLC22A2 Human methoxsalen increases expression ISO Slc22a2 (Mus musculus) 6480464 Methoxsalen results in increased expression of SLC22A2 protein CTD PMID:22173200 SLC22A2 Human methyltestosterone multiple interactions EXP 6480464 Methyltestosterone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human metoclopramide multiple interactions EXP 6480464 Metoclopramide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human metoprolol multiple interactions EXP 6480464 Metoprolol inhibits the reaction [SLC22A2 protein results in increased uptake of Metformin] CTD PMID:19740083 SLC22A2 Human mianserin multiple interactions EXP 6480464 Mianserin inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:23770354 SLC22A2 Human miconazole multiple interactions EXP 6480464 Miconazole inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human mirtazapine multiple interactions EXP 6480464 mirtazapine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human monobenzone multiple interactions EXP 6480464 monobenzone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human mosapride citrate dihydrate multiple interactions EXP 6480464 mosapride inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human Moxonidine multiple interactions EXP 6480464 moxonidine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human mycophenolic acid multiple interactions EXP 6480464 Mycophenolic Acid inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human myrtecaine multiple interactions EXP 6480464 myrtecaine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human N,N-diethyl-m-toluamide multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in increased methylation of SLC22A2 gene CTD PMID:33148267 SLC22A2 Human N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 1-Methyl-4-phenylpyridinium inhibits the reaction [SLC22A2 protein results in increased uptake of Cimetidine]; 1-Methyl-4-phenylpyridinium inhibits the more ... CTD PMID:12110607|PMID:15496291|PMID:16141367|PMID:16263091|PMID:19357179|PMID:19740083|PMID:27504015|PMID:32003934 SLC22A2 Human N-methyl-4-phenylpyridinium decreases uptake EXP 6480464 SLC22A2 gene polymorphism results in decreased uptake of 1-Methyl-4-phenylpyridinium CTD PMID:17220237 SLC22A2 Human N-methyl-4-phenylpyridinium increases uptake EXP 6480464 SLC22A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium CTD PMID:12110607|PMID:16141367|PMID:17220237|PMID:19740083|PMID:27504015|PMID:32003934 SLC22A2 Human N-methyl-4-phenylpyridinium increases transport EXP 6480464 SLC22A2 protein results in increased transport of 1-Methyl-4-phenylpyridinium CTD PMID:16211406|PMID:16263091 SLC22A2 Human N-methyl-4-phenylpyridinium increases import EXP 6480464 SLC22A2 results in increased import of 1-Methyl-4-phenylpyridinium CTD PMID:9260930 SLC22A2 Human N-methyl-4-phenylpyridinium multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 1-Methyl-4-phenylpyridinium affects the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:12440152 SLC22A2 Human N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine increases uptake EXP 6480464 SLC22A2 protein results in increased uptake of Ranitidine CTD PMID:16006492 SLC22A2 Human N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine increases uptake ISO Slc22a2 (Rattus norvegicus) 6480464 SLC22A2 protein results in increased uptake of Ranitidine CTD PMID:16006492 SLC22A2 Human N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 Ranitidine inhibits the reaction [SLC22A2 protein results in increased transport of 1-Methyl-4-phenylpyridinium]; Ranitidine inhibits the more ... CTD PMID:16141367|PMID:16263091 SLC22A2 Human nalbuphine multiple interactions EXP 6480464 Nalbuphine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human nandrolone multiple interactions EXP 6480464 Nandrolone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human naphthalene decreases expression ISO Slc22a2 (Rattus norvegicus) 6480464 naphthalene analog results in decreased expression of SLC22A2 mRNA CTD PMID:24976557 SLC22A2 Human naproxen decreases activity EXP 6480464 Naproxen results in decreased activity of SLC22A2 protein CTD PMID:12388633 SLC22A2 Human nefazodone multiple interactions EXP 6480464 nefazodone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human nicardipine multiple interactions EXP 6480464 Nicardipine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human nicotine multiple interactions EXP 6480464 Nicotine inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:23770354 SLC22A2 Human nicotine affects response to substance EXP 6480464 SLC22A2 gene SNP affects the susceptibility to Nicotine CTD PMID:25143296 SLC22A2 Human Nifekalant multiple interactions EXP 6480464 nifekalant inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human nimetazepam multiple interactions EXP 6480464 nimetazepam inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human nitenpyram decreases activity EXP 6480464 nitenpyram results in decreased activity of SLC22A2 protein CTD PMID:31364238 SLC22A2 Human nocodazole multiple interactions EXP 6480464 Nocodazole inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human norethisterone multiple interactions EXP 6480464 Norethindrone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human norfloxacin multiple interactions EXP 6480464 Norfloxacin inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human nortriptyline multiple interactions EXP 6480464 Nortriptyline inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human ochratoxin A decreases expression ISO Slc22a2 (Rattus norvegicus) 6480464 ochratoxin A results in decreased expression of SLC22A2 mRNA; ochratoxin A results in decreased expression more ... CTD PMID:12700408|PMID:16251485|PMID:18417182|PMID:30120945 SLC22A2 Human ochratoxin A multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 SLC22A2 protein affects the reaction [ochratoxin A results in increased expression of CASP3 mRNA]; SLC22A2 more ... CTD PMID:30120945 SLC22A2 Human ochratoxin A increases expression ISO Slc22a2 (Rattus norvegicus) 6480464 ochratoxin A results in increased expression of SLC22A2 mRNA; ochratoxin A results in increased expression more ... CTD PMID:30120945 SLC22A2 Human olanzapine multiple interactions EXP 6480464 olanzapine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human omeprazole multiple interactions EXP 6480464 Omeprazole inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human Ondansetron multiple interactions ISO Slc22a2 (Mus musculus) 6480464 Ondansetron inhibits the reaction [SLC22A2 protein results in increased uptake of Metformin] CTD PMID:24001450 SLC22A2 Human Ondansetron multiple interactions EXP 6480464 Ondansetron inhibits the reaction [SLC22A2 protein polymorphism results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]; Ondansetron inhibits more ... CTD PMID:21599003|PMID:24001450 SLC22A2 Human orlistat multiple interactions EXP 6480464 orlistat inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human orphenadrine multiple interactions EXP 6480464 Orphenadrine inhibits the reaction [SLC22A2 protein polymorphism results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]; Orphenadrine inhibits more ... CTD PMID:21599003 SLC22A2 Human oxaliplatin increases response to substance EXP 6480464 SLC22A2 protein results in increased susceptibility to Oxaliplatin CTD PMID:34252480 SLC22A2 Human oxaliplatin increases uptake EXP 6480464 SLC22A2 protein results in increased uptake of Oxaliplatin CTD PMID:38589558 SLC22A2 Human oxaliplatin increases import EXP 6480464 SLC22A2 protein results in increased import of Oxaliplatin CTD PMID:34252480 SLC22A2 Human oxaliplatin multiple interactions EXP 6480464 Dasatinib inhibits the reaction [SLC22A2 protein results in increased uptake of Oxaliplatin]; tetrahydropalmatine inhibits the more ... CTD PMID:34252480|PMID:38589558 SLC22A2 Human oxatomide multiple interactions EXP 6480464 oxatomide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human oxiconazole multiple interactions EXP 6480464 oxiconazole inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human oxybuprocaine multiple interactions EXP 6480464 benoxinate inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human oxybutynin multiple interactions EXP 6480464 oxybutynin inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human oxymetazoline multiple interactions EXP 6480464 Oxymetazoline inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human oxymetholone multiple interactions EXP 6480464 Oxymetholone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human ozone multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 [Ozone co-treated with Chlorine] results in increased expression of SLC22A2 mRNA CTD PMID:18636392 SLC22A2 Human p-aminohippuric acid multiple interactions EXP 6480464 p-Aminohippuric Acid inhibits the reaction [SLC22A2 protein results in increased uptake of Cimetidine] CTD PMID:15496291 SLC22A2 Human paraquat affects uptake EXP 6480464 SLC22A2 protein affects the uptake of Paraquat CTD PMID:17495125 SLC22A2 Human paraquat multiple interactions ISO Slc22a2 (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in decreased expression of SLC22A2 mRNA; Melatonin inhibits the reaction more ... CTD PMID:23963992 SLC22A2 Human paraquat affects uptake ISO Slc22a2 (Rattus norvegicus) 6480464 SLC22A2 protein affects the uptake of Paraquat CTD PMID:17495125 SLC22A2 Human paraquat increases response to substance EXP 6480464 SLC22A2 protein results in increased susceptibility to Paraquat CTD PMID:17495125 SLC22A2 Human paroxetine multiple interactions EXP 6480464 Paroxetine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human parthenolide multiple interactions EXP 6480464 parthenolide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human pecazine multiple interactions EXP 6480464 mepazine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human pentamidine multiple interactions EXP 6480464 Pentamidine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human perfluorodecalin multiple interactions EXP 6480464 perfluorodecalin inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human perfluorohexanesulfonic acid multiple interactions EXP 6480464 [perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluorohexanesulfonic acid] results in increased expression more ... CTD PMID:38603627 SLC22A2 Human perfluorohexanesulfonic acid increases expression ISO Slc22a2 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of SLC22A2 mRNA CTD PMID:37995155 SLC22A2 Human perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluorohexanesulfonic acid] results in increased expression more ... CTD PMID:38603627 SLC22A2 Human perfluorooctanoic acid multiple interactions EXP 6480464 [perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluorohexanesulfonic acid] results in increased expression more ... CTD PMID:38603627 SLC22A2 Human pergolide multiple interactions EXP 6480464 Pergolide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human perhexiline multiple interactions EXP 6480464 Perhexiline inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human permethrin multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in increased methylation of SLC22A2 gene CTD PMID:33148267 SLC22A2 Human perphenazine multiple interactions EXP 6480464 Perphenazine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human Phenelzine multiple interactions EXP 6480464 Phenelzine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human phenformin multiple interactions EXP 6480464 Phenformin inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human Phenoxybenzamine multiple interactions EXP 6480464 Phenoxybenzamine inhibits the reaction [SLC22A2 protein affects the transport of Metformin]; Phenoxybenzamine inhibits the reaction more ... CTD PMID:12110607|PMID:18728938|PMID:21599003 SLC22A2 Human Phenoxybenzamine decreases activity EXP 6480464 Phenoxybenzamine results in decreased activity of SLC22A2 protein CTD PMID:12110607 SLC22A2 Human phentolamine multiple interactions EXP 6480464 Phentolamine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human phenyltoloxamine multiple interactions EXP 6480464 phenyltoloxamine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human PhIP multiple interactions EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [SLC22A2 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide] CTD PMID:30189235 SLC22A2 Human PhIP decreases activity EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased activity of SLC22A2 protein CTD PMID:30189235 SLC22A2 Human pioglitazone multiple interactions EXP 6480464 pioglitazone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human Piracetam multiple interactions EXP 6480464 Piracetam inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human piroxicam decreases activity EXP 6480464 Piroxicam results in decreased activity of SLC22A2 protein CTD PMID:12388633 SLC22A2 Human Potassium 2,6-dihydroxytriazinecarboxylate multiple interactions ISO Slc22a2 (Mus musculus) 6480464 Allopurinol inhibits the reaction [potassium oxonate results in decreased expression of SLC22A2 mRNA]; Allopurinol inhibits more ... CTD PMID:21909718|PMID:22865646|PMID:22967667|PMID:25499818 SLC22A2 Human Potassium 2,6-dihydroxytriazinecarboxylate increases expression ISO Slc22a2 (Mus musculus) 6480464 potassium oxonate results in increased expression of SLC22A2 protein CTD PMID:25499818 SLC22A2 Human Potassium 2,6-dihydroxytriazinecarboxylate decreases expression ISO Slc22a2 (Mus musculus) 6480464 potassium oxonate results in decreased expression of SLC22A2 mRNA; potassium oxonate results in decreased expression more ... CTD PMID:21909718|PMID:22865646|PMID:22967667 SLC22A2 Human pralidoxime multiple interactions EXP 6480464 pralidoxime inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human prazosin multiple interactions EXP 6480464 Prazosin inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human prednisone multiple interactions EXP 6480464 Prednisone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human pridinol multiple interactions EXP 6480464 pridinol inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human primaquine multiple interactions EXP 6480464 Primaquine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human prinomastat multiple interactions EXP 6480464 prinomastat inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human probenecid multiple interactions ISO Slc22a2 (Mus musculus) 6480464 Probenecid inhibits the reaction [potassium oxonate results in decreased expression of SLC22A2 mRNA]; Probenecid inhibits more ... CTD PMID:22865646|PMID:22967667 SLC22A2 Human procyclidine multiple interactions EXP 6480464 Procyclidine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human progesterone multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 Progesterone inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:9830022 SLC22A2 Human promazine multiple interactions EXP 6480464 Promazine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human Propantheline multiple interactions EXP 6480464 Propantheline inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human Proparacaine multiple interactions EXP 6480464 proxymetacaine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human propranolol multiple interactions EXP 6480464 Propranolol inhibits the reaction [SLC22A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Propranolol inhibits the more ... CTD PMID:19740083 SLC22A2 Human psoralen increases expression ISO Slc22a2 (Mus musculus) 6480464 Ficusin results in increased expression of SLC22A2 mRNA; Ficusin results in increased expression of SLC22A2 more ... CTD PMID:22173200 SLC22A2 Human pyrimethamine multiple interactions EXP 6480464 Pyrimethamine inhibits the reaction [SLC22A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:27504015 SLC22A2 Human quercetin multiple interactions ISO Slc22a2 (Mus musculus) 6480464 Quercetin inhibits the reaction [potassium oxonate results in decreased expression of SLC22A2 mRNA]; Quercetin inhibits more ... CTD PMID:21909718 SLC22A2 Human quercetin multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 Quercetin inhibits the reaction [Fructose results in decreased expression of SLC22A2 mRNA]; Quercetin inhibits the more ... CTD PMID:19605544 SLC22A2 Human quinidine multiple interactions EXP 6480464 Quinidine inhibits the reaction [SLC22A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Quinidine inhibits the more ... CTD PMID:16141367|PMID:21599003 SLC22A2 Human quinine multiple interactions EXP 6480464 Quinine inhibits the reaction [SLC22A2 protein results in increased transport of 1-Methyl-4-phenylpyridinium]; Quinine inhibits the more ... CTD PMID:16263091|PMID:19357179|PMID:21599003|PMID:27504015 SLC22A2 Human quinine decreases activity EXP 6480464 Quinine results in decreased activity of SLC22A2 protein CTD PMID:31830554 SLC22A2 Human rabeprazole multiple interactions EXP 6480464 Rabeprazole inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human raloxifene multiple interactions EXP 6480464 Raloxifene Hydrochloride inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human ranitidine increases uptake EXP 6480464 SLC22A2 protein results in increased uptake of Ranitidine CTD PMID:16006492 SLC22A2 Human ranitidine increases uptake ISO Slc22a2 (Rattus norvegicus) 6480464 SLC22A2 protein results in increased uptake of Ranitidine CTD PMID:16006492 SLC22A2 Human ranitidine multiple interactions EXP 6480464 Ranitidine inhibits the reaction [SLC22A2 protein results in increased transport of 1-Methyl-4-phenylpyridinium]; Ranitidine inhibits the more ... CTD PMID:16141367|PMID:16263091 SLC22A2 Human resveratrol multiple interactions EXP 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC22A2 mRNA CTD PMID:23557933 SLC22A2 Human rutin multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 Rutin inhibits the reaction [Fructose results in decreased expression of SLC22A2 mRNA]; Rutin inhibits the more ... CTD PMID:19605544 SLC22A2 Human semustine multiple interactions EXP 6480464 Semustine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human sildenafil citrate multiple interactions EXP 6480464 Sildenafil Citrate inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human sodium arsenite decreases expression ISO Slc22a2 (Mus musculus) 6480464 sodium arsenite results in decreased expression of SLC22A2 mRNA CTD PMID:37682722 SLC22A2 Human sodium dichromate increases expression ISO Slc22a2 (Rattus norvegicus) 6480464 sodium bichromate results in increased expression of SLC22A2 mRNA CTD PMID:12325037 SLC22A2 Human sparteine multiple interactions EXP 6480464 Sparteine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human spiperone multiple interactions EXP 6480464 Spiperone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human spironolactone multiple interactions EXP 6480464 Spironolactone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human streptozocin decreases expression ISO Slc22a2 (Rattus norvegicus) 6480464 Streptozocin results in decreased expression of SLC22A2 protein CTD PMID:19605544 SLC22A2 Human strychnine multiple interactions EXP 6480464 Strychnine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human sulconazole multiple interactions EXP 6480464 sulconazole inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human sulindac decreases activity EXP 6480464 Sulindac results in decreased activity of SLC22A2 protein CTD PMID:12388633 SLC22A2 Human tacrine multiple interactions EXP 6480464 Tacrine inhibits the reaction [SLC22A2 protein polymorphism results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]; Tacrine inhibits more ... CTD PMID:21599003 SLC22A2 Human Tegafur multiple interactions EXP 6480464 Tegafur inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human telmisartan multiple interactions EXP 6480464 telmisartan inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human terbutaline multiple interactions EXP 6480464 Terbutaline inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human terconazole multiple interactions EXP 6480464 terconazole inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human testosterone multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 Testosterone inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:9830022 SLC22A2 Human tetracaine multiple interactions EXP 6480464 Tetracaine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human tetrachloromethane increases expression ISO Slc22a2 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of SLC22A2 mRNA CTD PMID:16644059 SLC22A2 Human tetraethylammonium multiple interactions EXP 6480464 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole inhibits the reaction [SLC22A2 protein results in increased import of Tetraethylammonium]; 3-amino-1-methyl-5H-pyrido(4,3-b)indole inhibits the more ... CTD PMID:15496291|PMID:16141367|PMID:17287197|PMID:19357179|PMID:23770354|PMID:27989701|PMID:28629854|PMID:30189235|PMID:32003934 SLC22A2 Human tetraethylammonium increases uptake EXP 6480464 SLC22A2 protein results in increased uptake of Tetraethylammonium CTD PMID:16006492|PMID:17220237|PMID:21256917|PMID:23770354|PMID:27989701 SLC22A2 Human tetraethylammonium decreases uptake EXP 6480464 SLC22A2 gene polymorphism results in decreased uptake of Tetraethylammonium CTD PMID:17220237 SLC22A2 Human tetraethylammonium increases uptake ISO Slc22a2 (Rattus norvegicus) 6480464 SLC22A2 protein results in increased uptake of Tetraethylammonium CTD PMID:12440152|PMID:16006492|PMID:9830022 SLC22A2 Human tetraethylammonium increases import EXP 6480464 SLC22A2 protein results in increased import of Tetraethylammonium; SLC22A2 results in increased import of Tetraethylammonium CTD PMID:28629854|PMID:30189235|PMID:9260930 SLC22A2 Human tetraethylammonium affects transport EXP 6480464 SLC22A2 protein affects the transport of Tetraethylammonium CTD PMID:15496291|PMID:16141367 SLC22A2 Human tetraethylammonium multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 1-Methyl-4-phenylpyridinium affects the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium]; Chlorpheniramine affects the more ... CTD PMID:12440152|PMID:9830022 SLC22A2 Human tetrahydropalmatine multiple interactions EXP 6480464 tetrahydropalmatine inhibits the reaction [SLC22A2 protein results in increased import of Oxaliplatin] CTD PMID:34252480 SLC22A2 Human tetryzoline multiple interactions EXP 6480464 tetrahydrozoline inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human thalidomide multiple interactions EXP 6480464 Thalidomide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human thiacloprid decreases activity EXP 6480464 thiacloprid metabolite results in decreased activity of SLC22A2 protein; thiacloprid results in decreased activity of more ... CTD PMID:31364238 SLC22A2 Human thiamethoxam decreases activity EXP 6480464 Thiamethoxam results in decreased activity of SLC22A2 protein CTD PMID:31364238 SLC22A2 Human thioridazine multiple interactions EXP 6480464 Thioridazine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human tolazoline multiple interactions EXP 6480464 Tolazoline inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human tolterodine tartrate multiple interactions EXP 6480464 Tolterodine Tartrate inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human trazodone multiple interactions EXP 6480464 Trazodone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human triamcinolone acetonide multiple interactions EXP 6480464 Triamcinolone Acetonide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human triazolam multiple interactions EXP 6480464 Triazolam inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:23770354 SLC22A2 Human Trihexyphenidyl multiple interactions EXP 6480464 Trihexyphenidyl inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human trimellitic anhydride decreases expression ISO Slc22a2 (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of SLC22A2 mRNA CTD PMID:19042947 SLC22A2 Human trimipramine multiple interactions EXP 6480464 Trimipramine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human Tripelennamine multiple interactions EXP 6480464 Tripelennamine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate multiple interactions EXP 6480464 Atropine inhibits the reaction [SLC22A2 protein results in increased transport of 1-Methyl-4-phenylpyridinium]; Atropine inhibits the more ... CTD PMID:16263091|PMID:21599003|PMID:23770354 SLC22A2 Human tropisetron multiple interactions EXP 6480464 tropisetron inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human trospium chloride decreases activity EXP 6480464 trospium chloride results in decreased activity of SLC22A2 protein CTD PMID:25466967 SLC22A2 Human valdecoxib multiple interactions EXP 6480464 valdecoxib inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of SLC22A2 mRNA CTD PMID:25979313 SLC22A2 Human vancomycin multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 JBP 485 inhibits the reaction [Vancomycin results in decreased expression of SLC22A2 mRNA]; JBP 485 more ... CTD PMID:29964132 SLC22A2 Human vancomycin increases expression ISO Slc22a2 (Rattus norvegicus) 6480464 Vancomycin results in increased expression of SLC22A2 protein CTD PMID:39041788 SLC22A2 Human vancomycin decreases expression ISO Slc22a2 (Rattus norvegicus) 6480464 Vancomycin results in decreased expression of SLC22A2 mRNA; Vancomycin results in decreased expression of SLC22A2 more ... CTD PMID:29964132 SLC22A2 Human varenicline affects response to substance EXP 6480464 SLC22A2 gene SNP affects the susceptibility to Varenicline CTD PMID:25143296 SLC22A2 Human verapamil multiple interactions EXP 6480464 Verapamil inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human verapamil multiple interactions ISO Slc22a2 (Rattus norvegicus) 6480464 Verapamil inhibits the reaction [SLC22A2 protein results in increased uptake of mepiquat] CTD PMID:33639197 SLC22A2 Human VX-745 multiple interactions EXP 6480464 VX-745 inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human Xylometazoline multiple interactions EXP 6480464 xylometazoline inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human zafirlukast multiple interactions EXP 6480464 zafirlukast inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 SLC22A2 Human zolpidem multiple interactions EXP 6480464 zolpidem inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003